Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Stable Mortality Rates Despite Rising Incidence of Melanoma
1
Mins
May 2024
Mortality rates of Melanoma have remained stable despite rising incidence, with reasons for this disparity still unclear.
Read more
1
Mins
16th November 2015
Revolutionary Computer Program Diagnoses Cancer in 2 Days
NOVEL diagnostic technology based on advanced self-learning computer algorithms may identify the source of cancer in a patient with 85% certainty…
2
Mins
12th November 2015
New German Data Show the Use of Endocuff Vision® May Improve Adenoma Detection Rates and Reduce Health System Costs
London, Wednesday 11 November 2015, 07:00 GMT: Norgine B.V. today announced new data showing that ENDOCUFF VISION®, a colonoscope device…
3
Mins
1st October 2015
Large TAILORx Outcomes Study Demonstrates 99% of Patients with Low Oncotype DX® Recurrence Score® Results Were Breast Cancer Relapse-Free following Five Years of Hormone Therapy Alone
GENEVA, Switzerland, [September 28, 2015] – Genomic Health today announced the presentation of the first results1 from the Trial Assigning…
5
Mins
24th September 2015
NICE Recommends Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia
London, 24 September 2015 – Gilead Sciences’ Zydelig® (idelalisib) has today been recommended by the National Institute for Health and Care Excellence…
1
Mins
17th August 2015
More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip
PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.
1
Mins
17th August 2015
Disabling Ability of Lymphoma to Escape Immune Response May Trigger New Treatments
RESTORING the power of natural killer (NK) cells in the vicinity of lymphoma tumours may catalyse the development of new therapies, according to…
6
Mins
6th July 2015
Second-Line Cetuximab Active beyond Progression in Quadruple Wild-Type Patients with Metastatic Colorectal Cancer
BARCELONA-LUGANO, 4 July 2015 – Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes…
8
Mins
3rd July 2015
Studies Confirm Regorafenib Benefit in Pre-Treated Metastatic Colorectal Cancer
BARCELONA-LUGANO, 3 July 2015 – The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated…
Loading posts...
« Previous
1
…
27
28
29
30
31
32
Next »